Drug Concentration Articles & Analysis
29 articles found
The MDCK permeability assay is a critical technique employed in pharmacology and drug development to evaluate the permeability of drug candidates across epithelial cell layers. ...
This article explores the profound impact of nanotechnology on drug delivery systems and its correlation with formulation development services Enhanced Drug Delivery and Targeting One of the most significant contributions of nanotechnology to pharmaceutical formulations is its ability to enhance drug delivery and targeting. Through the design ...
Pharmacodynamics: The Drug’s Effect on the Body Pharmacodynamics examines the biological and physiological effects of drugs and their mechanisms of action. It focuses on the relationship between drug concentration at the site of action and the resulting therapeutic or toxic response. ...
Role of Liposomes in Drug Delivery The structure of liposomes, consisting of an aqueous core enclosed by a lipid bilayer, allows for the encapsulation of both hydrophilic and lipophilic drugs. ...
ApplicationsORD is commonly used to determine the absolute and relative configurations of compounds, monitor changes in chiral centers during chemical or biological processes (such as enzymatic reactions), and assess the purity and concentration of chiral drugs.3. Information ContentORD primarily provides information about chiral centers, such as their absolute ...
Ensuring the purity, concentration and conformational stability of the drug is crucial, which not only relates to the efficacy of the drug, but also affects its safety.Ultraviolet spectroscopy technique is based on the absorption characteristics of antibody proteins to specific wavelengths of ultraviolet light, and can provide rapid and ...
Antibody-drug conjugates (ADCs) are a new class of drugs that combine the advantages of both antibodies and small molecule toxins. ...
Antibody-drug conjugates (ADCs) represent a groundbreaking class of therapeutics that combine the specificity of monoclonal antibodies (mAbs) with the potent cytotoxic effects of small-molecule drugs. ...
Prolonging Drug Half-Life The process of PEGylation, which involves attaching PEG chains to therapeutic molecules, has been a game-changer in prolonging the half-life of drugs. ...
Conventional liposomes As a drug delivery system, traditional liposomes can change the pharmacokinetic properties and tissue distribution of tumor drugs, enhance the target aggregation concentration of drugs, and enhance drug efficacy. ...
Hydrophilic drugs stay in the aqueous core, while hydrophobic drugs integrate into the lipid bilayer. Active loading: This method uses transmembrane gradients (differences in pH or ion concentration) to drive the drug into the liposome core after formation. This allows for higher drug loading and better control ...
When labeling, the ratio of biotin to antibody is affected by the antibody concentration. When labeling with biotin, the antibody must not contain sodium azide, BSA, glycine, Tris or any other additives with free amino groups. ...
Nanotechnology has not only received attention and applications in the field of drug delivery, but also has achieved many successes in the field of tissue engineering. ...
The interaction between HCPs and therapeutic proteins is first removed by anionic surfactants, so that HCPs can be enriched using a molecular weight cut-off (MWCO) ultrafiltration step, and then identified by a "shotgun" quantitative proteomics technique and analysis of HCP in therapeutic protein drugs. This strategy reduces the concentration span of HCP by a ...
Patient-centric drug development is a divisive concept. Dismissed as a buzzword by some. ...
Once injected into the body, microspheres are gradually degraded in the body, allowing the drug to be released slowly at a certain rate, maintaining the drug concentration in the blood at the site of the lesion, thereby prolonging the half-life of the drug and achieving long-acting sustained release. ...
When the microneedle delivers the drug, the active ingredient is loaded into the microneedle array, and the concentration gradient between the drug and the subcutaneous tissue fluid forms a driving force, causing the drug to be slowly released into the body. ...
Mechanism of action of ADC drugs Antibody conjugate drugs (ADCs) are a type of novel antitumor drugs in continuous development. They combine the high specificity of monoclonal antibody drugs with the high activity of small molecule cytotoxic drugs, which can improve the targeting of antitumor ...
Advantages of Liposomes as Drug Delivery Vehicles l As drug delivery vehicles, liposomes have low toxicity and immunogenicity, and the high biocompatibility and biodegradability of their components—phospholipids can increase the in vivo drug concentrations and protect drugs from degradation. l They can be ...
Pulmonary administration of drug-loaded liposomes can prolong the topical and systemic therapeutic effects of drugs. ...